Literature DB >> 19446869

Robotic surgery in gynecologic oncology: impact on fellowship training.

Anna V Hoekstra1, Jacqueline M Morgan, John R Lurain, Barbara M Buttin, Diljeet K Singh, Julian C Schink, M Patrick Lowe.   

Abstract

OBJECTIVES: To report the impact of a new robotic surgery program on the surgical training of gynecologic oncology fellows over a 12 month period of time.
METHODS: A robotic surgery program was introduced into the gynecologic oncology fellowship program at Northwestern University Feinberg School of Medicine in June 2007. A database of patients undergoing surgical management of endometrial and cervical cancer between July 2007 and July 2008 was collected and analyzed. Changes in fellow surgical training were measured and analyzed.
RESULTS: Fellow surgical training for endometrial and cervical cancer underwent a dramatic transition in 12 months. The proportion of patients undergoing minimally invasive surgery increased from 3.3% (4/110 patients) to 43.5% (47/108 patients). Fellow training transitioned from primarily an open approach (94.4%) to a minimally invasive approach (11% laparoscopic, 49% robotic, 40% open) for endometrial cancer stagings, and from an open approach (100%) to an open (50%) and robotic (50%) approach for radical hysterectomies. Fellow participation in robotic procedures increased from 45% in the first 3 months to 72% within 6 months, and 92% by 12 months. The role of the fellow in robotic cases transitioned from bedside assistant to console operator within 3 months.
CONCLUSIONS: Fellow surgical training underwent a dramatic change with the introduction of a robotic surgery program. The management of endometrial and cervical cancer was impacted the most by robotics. Robotic surgery broadened fellowship surgical training, but balanced surgical training and standardized fellow training modules remain challenges for fellowship programs.

Entities:  

Mesh:

Year:  2009        PMID: 19446869     DOI: 10.1016/j.ygyno.2009.04.022

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

1.  Robotic-assisted total laparoscopic hysterectomy and staging for the treatment of endometrial cancer: a comparison with conventional laparoscopy and abdominal approaches.

Authors:  Ricardo Estape; Nicholas Lambrou; Eric Estape; Oscar Vega; Trisha Ojea
Journal:  J Robot Surg       Date:  2011-06-25

Review 2.  Learning tools and simulation in robotic surgery: state of the art.

Authors:  Nicolas C Buchs; François Pugin; Francesco Volonté; Philippe Morel
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

3.  Successful incorporation of robotic surgery into gynecologic oncology fellowship training.

Authors:  Pamela T Soliman; David Iglesias; Mark F Munsell; Michael Frumovitz; Shannon N Westin; Alpa M Nick; Kathleen M Schmeler; Pedro T Ramirez
Journal:  Gynecol Oncol       Date:  2013-09-19       Impact factor: 5.482

4.  Surgical outcomes of robotic-assisted surgical staging for endometrial cancer are equivalent to traditional laparoscopic staging at a minimally invasive surgical center.

Authors:  Joel Cardenas-Goicoechea; Sarah Adams; Suneel B Bhat; Thomas C Randall
Journal:  Gynecol Oncol       Date:  2010-02-07       Impact factor: 5.482

5.  Robotic surgical management of endometrial cancer in octogenarians and nonagenarians: analysis of perioperative outcomes and review of the literature.

Authors:  M Patrick Lowe; Saurabh Kumar; Peter R Johnson; Scott A Kamelle; Donald H Chamberlain; Todd D Tillmanns
Journal:  J Robot Surg       Date:  2010-06-11

6.  Robotic surgery training in gynecologic fellowship programs in the United States.

Authors:  Soorena Fatehchehr; Ghazaleh Rostaminia; Michael O Gardner; Elisa Ramunno; Nora M Doyle
Journal:  JSLS       Date:  2014 Jul-Sep       Impact factor: 2.172

7.  Surgical outcomes of robotic radical hysterectomy using three robotic arms versus conventional multiport laparoscopy in patients with cervical cancer.

Authors:  Ga Won Yim; Sang Wun Kim; Eun Ji Nam; Sunghoon Kim; Hee Jung Kim; Young Tae Kim
Journal:  Yonsei Med J       Date:  2014-09       Impact factor: 2.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.